Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL478999 | 0.70 | MEN1 (0.31) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL891446 | 0.67 | ALOX5 (0.56) | TTRALOX5PTGS2MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL28225131 | 0.65 | ALOX5 (0.54) | TTRALOX5PTGS2MAPTMAPK1 | |
| SCHEMBL28718131 | 0.58 | ALOX5 (0.46) | ALOX5PTGS2MAPTMEN1KMT2A | |
| SCHEMBL2649 | 0.57 | TTR (0.30) | TTR | |
| SCHEMBL14129376 | 0.57 | PTPRC (0.48) | TTRALOX5PTGS2MAPTMAPK1 | |
| SCHEMBL18889482 | 0.56 | PTPRC (0.41) | ALOX5PTGS2MAPTMAPK1MEN1 | |
| SCHEMBL3275002 | 0.55 | PABPC1 (0.42) | — | |
| SCHEMBL18992911 | 0.54 | MAPT (0.41) | ALOX5PTGS2MAPTMAPK1MEN1 | |
| SCHEMBL11504082 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2303588-A2 | TEMPORARY TATTOO DECALS FOR DETECTING THE PRESENCE OF AN ANALYTE | Kimberly-Clark Worldwide, Inc. (US) | 2011-04-06 | — | — | EP | claimed |
| WO-2010001275-A2 | TEMPORARY TATTOO DECALS FOR DETECTING THE PRESENCE OF AN ANALYTE | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-01-07 | — | — | WO | claimed |
| US-20090325221-A1 | Temporary Tattoo Decals for Detecting the Presence of an Analyte | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-12-31 | — | — | US | claimed |
| EP-1194117-B1 | AGENT FOR DYEING KERATIN CONTAINING FIBRES | HENKEL KGAA (DE) | 2005-06-01 | — | — | EP | claimed |
| US-12545878-B2 | Systems and apparatuses for cellular therapeutics manufacture | BRUKER CELLULAR ANALYSIS, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3423433-B1 | SULFAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES | BIO PHARM SOLUTIONS CO LTD (KR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250179404-A1 | SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE | BRUKER SPATIAL BIOLOGY, INC. | 2025-06-05 | — | — | US | disclosed |
| CN-118900689-A | Oxazolidinone liposome compositions | 阿卡格拉医药公司 | 2024-11-05 | — | — | CN | disclosed |
| EP-4277974-A1 | SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE | Berkeley Lights, Inc. (US) | 2023-11-22 | — | — | EP | disclosed |
| CN-117015597-A | Systems, devices, and methods for cellular therapeutic agent manufacture | 伯克利之光生命科技公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20230313107-A1 | SYSTEMS AND APPARATUSES FOR CELLULAR THERAPEUTICS MANUFACTURE | Berkeley Lights, Inc. (US) | 2023-10-05 | — | — | US | disclosed |
| US-20220325240-A1 | SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE | BRUKER CELLULAR ANALYSIS, INC. | 2022-10-13 | — | — | US | disclosed |
| WO-2010001275-A2 | TEMPORARY TATTOO DECALS FOR DETECTING THE PRESENCE OF AN ANALYTE | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-01-07 | — | — | WO | disclosed |
| US-20090325221-A1 | Temporary Tattoo Decals for Detecting the Presence of an Analyte | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| EP-1029238-B1 | SAMPLING AND ANALYSIS OF REACTIONS BY TRAPPING REACTION COMPONENTS ON A SORBENT | SYMYX TECHNOLOGIES INC (US) | 2004-05-12 | — | — | EP | disclosed |
| US-6667009-B1 | Analysis apparatus comprising blocks having wells and adsorber layers on the surfaces for preferential screening of combinatorial chemistry libraries and transformations | SYMYX TECHNOLOGIES, INC. | 2003-12-23 | — | — | US | disclosed |
| EP-1287882-A2 | Method for screening a catalyst library | Symyx Technologies, Inc. (US) | 2003-03-05 | — | — | EP | disclosed |
| US-6410332-B1 | ANALYZING LIBRARY OF MIXTURES; OBTAIN SAMPLE FROM LIBRARY, INCUBATE WITH SORBENT, TRAP PORTION OF SAMPLE ON SORBENT, DETECTING COMPONENTS OF THE FLUID SAMPLE TRAPPED ON THE SORBENT | SYMYX TECHNOLOGIES, INC. | 2002-06-25 | — | — | US | disclosed |
| US-4883676-A | CONTROLLED COMBUSTION OF SAWDUST | THE GRIFFITH LABORATORIES, LIMITED (CA) | 1989-11-28 | — | — | US | disclosed |
| EP-0246847-A2 | Liquid smoke | THE GRIFFITH LABORATORIES, LIMITED (CA) | 1987-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545878-B2 | Systems and apparatuses for cellular therapeutics manufacture | CD4, IL2, ICOS | TTR 101/4885ALOX5 3199/4885PTGS2 2880/4885 |
| US-20250179404-A1 | SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE | ICOS, PBK, NFATC1 | TTR 505/4885ALOX5 1680/4885PTGS2 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.